000			02026 a2200529 4500
005			20250514073942.0
264		0	_c20031017
008			200310s 0 0 eng d
022			_a0923-7534
024	7		_a10.1093/annonc/mdg328 _2doi
040			_aNLM _beng _cNLM
100	1		_aPolee, M B
245	0	0	_aPhase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cAug 2003
300			_a1253-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aEsophageal Neoplasms _xdrug therapy
650	0	4	_aEsophagectomy _xmethods
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNeoplasm Staging
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aProbability
650	0	4	_aPrognosis
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
700	1		_aTilanus, H W
700	1		_aEskens, F A L M
700	1		_aHoekstra, R
700	1		_aVan der Burg, M E L
700	1		_aSiersema, P D
700	1		_aStoter, G
700	1		_aVan der Gaast, A
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 14 _gno. 8 _gp. 1253-7
856	4	0	_uhttps://doi.org/10.1093/annonc/mdg328 _zAvailable from publisher's website
999			_c12658473 _d12658473